What to Expect From Gilead Earnings
Tuesday after the U.S. markets close, Gilead Sciences will report its fourth-quarter financial results.
Tuesday after the U.S. markets close, Gilead Sciences will report its fourth-quarter financial results.
Here are the five biotech stocks that are loved the most by portfolio managers, according to Cowen analysts.
Biogen Idec shares hit a new multiyear high Friday morning following the better-than-expected fourth-quarter earnings.
AbbVie reported better-than-expected fourth-quarter financial results Friday before the markets open.
Celgene Corp. (NASDAQ: CELG) reported better-than-expected fourth-quarter earnings on Thursday morning.
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. For the majority of the selected stocks, short interest is down.
Here are five stocks rated Outperform at Baird that are seeing a high percentage of pulmonary Medicare admissions.
Pfizer reported better-than-expected fourth-quarter earnings Tuesday before the U.S. markets opened.
Teva Pharmaceutical announced on Monday that the FDA approved the first generic equivalent to Nexium delayed-release capsules in the United States.
Heart disease, obesity and diabetes have become epidemics in America. The drag on the American health industry and the overall economy will not, therefore improve.
A new report from RBC focuses on top small-cap biotech stocks with key data readouts coming in 2015. Binary events are often the key element in moving a biotech stock higher.
In a study about how activity on Twitter can predict health outcomes, researchers found tweets on the social network can predict heart disease patterns.
UnitedHealth Group reported better than expected fourth-quarter and full-year 2014 results before markets opened Wednesday morning.
A new Wood Mackenzie report paints a complex picture of what to expect in 2015. The report identifies several trends beyond the simple narrative that low prices will force a cutback in drilling.
Johnson & Johnson reported better than expected fourth-quarter results Tuesday before the market open.